Methods of using igf1r and abl kinase modulators

Details Methods of using igf1r and abl kinase modulators Methods of using igf1r and abl kinase modulators

A - Human Necessities

61

K

A61K 31/506 (2006.01) A61K 31/519 (2006.01) A61K 31/5355 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2656290

The invention provides methods of treating cancer with a compound which inhibits kinases, more specifically IGF1R and Abl, in combination with treatments(s) selected from surgery, radiation, monoclonal antibody, bone marrow or peripheral blood stem cell transplantation, and one or more chemotherapeutic agent(s).

L'invention concerne des procédés de traitement du cancer avec un composé qui inhibe les kinases, plus spécifiquement IGF1R et Abl, en combinaison avec un ou plusieurs traitements choisis parmi la chirurgie, les rayonnements, les anticorps monoclonaux, les transplantations de cellules souches du sang périphérique ou de la moelle épinière et un ou plusieurs agents chimiothérapeutiques.

Affiliated with

Also associated with

Rating

Methods of using igf1r and abl kinase modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of using igf1r and abl kinase modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using igf1r and abl kinase modulators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1812535